| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Abuse Panel 8, with Confirmation, Serum or Plasma
Test CodeDAPN8Q or 31689
CPT Codes
80307
Preferred Specimen
10 mL plasma collected in a sodium fluoride or sodium fluoride/potassium oxalate (gray-top) tube
Minimum Volume
5 mL
Other Acceptable Specimens
Whole blood collected in a sodium fluoride or sodium fluoride/potassium oxalate (gray-top) tube
or
Serum collected in a red-top tube (no gel)
or
Serum collected in a red-top tube (no gel)
Transport Temperature
Refrigerated
Specimen Stability
Plasma and Whole blood
Room temperature: 24 hours
Refrigerated: 7 days
Frozen: 30 days
Serum
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days
Room temperature: 24 hours
Refrigerated: 7 days
Frozen: 30 days
Serum
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum separator tube
Methodology
Immunoassay, Chromatography/Mass Sectrometry
Setup Schedule
Daily
Report Available
Next day
Limitations
All positive drug screens are confirmed and quantitated. CPT coding varies by drug confirmed.
Reference Range
See Laboratory Report
Clinical Significance
Drug Abuse Panel 8, with Confirmation, Serum or Plasma - The serum or plasma concentration of a drug is measured as guide to individualization of therapy. Additionally, the problem of noncompliance with prescribed medications during continuing therapy, particularly in the pain management field, is an elusive cause of therapeutic failure.
Performing Laboratory
Quest Diagnostics
